000423DEEJSZSE

Dong-E-E-Jiao Co., Ltd.

东阿阿胶

000423

Shenzhen Stock Exchange

BoardMain Board of Shenzhen Stock Exchange
IndustryPharmaceutical Manufacturing
ISINCNE0000006Y9
ListedJuly 29, 1996
Websitewww.dongeejiao.com
IR Emaildeejdb@dongeejiao.com
Phone(+86)531-88800423
Sourcecninfo.com.cn
AddressNo.78, Ajiao Street, Dong'e County, Shandong

Company Overview

Dong-E-E-Jiao Co., Ltd. is a leading manufacturer in the pharmaceutical sector, primarily engaged in the research, development, production, and sales of Ejiao (donkey-hide gelatin) and its related products, as well as other Traditional Chinese Patent Medicines. Established in 1996 and based in Dong’e County, Shandong Province, the company is recognized for its commitment to quality and innovation in the health and wellness industry, positioning itself as a pioneer in health tonics and a model for high-quality development in Traditional Chinese Medicine. The company's main product lines include donkey-hide gelatin, which has a rich historical significance in Chinese medicine, and a variety of health-focused products such as Compound Ejiao Syrup, Peach Blossom Lady Ejiao Cake, and Instant Ejiao Powder. Dong-E-E-Jiao has established a strong market presence, being the top-selling brand in its category and continuously enhancing its product offerings through technological advancements and quality control measures. The company aims to uphold its reputation as a trusted leader in health preservation while promoting the essence of Traditional Chinese Medicine.

AI-generated from company disclosures and CNInfo data.

Company Profile

The company takes the “life-care” as its mission, adheres to the vision of “kindness, genuine inheritance and innovation”, upholds the commitment of “establishing trust for quality, boosting ambition for team, setting example for industry, establishing destiny for people and holding national spirit”, taking “the most trusted health leader” as brand-new vision, focusing on customer demand and experience, continuously consolidating the top brand of “Nourishing National Treasure, Dong’e Ejiao”, and continuously absorbing traditional culture of TCM for three thousand years and essence of nourishing. We will continuously and firmly improve the quality of donkey-hide gelatin through scientific and technological innovation and strict quality control of the whole industrial chain. We are committed to building a leading brand with Chinese characteristics and international vision in the nourishing industry. 1. Strong brand edge: “Ejiao originates from Dong’e County, hence its name “Ejiao”. As a time-honored Chinese enterprise rooted in the values of integrity and innovation, it is situated in Dong’e County, Shandong Province – the birthplace of authentic Ejiao, boasting a strong advantage in consumer mindshare and renowned as “the leading brand in nourishment and health preservation”. As a role model among traditional Chinese medicine (TCM) enterprises for inheriting the essence while pursuing innovation, Dong’e Ejiao stands as the pacesetter in the gel-based TCM industry. It serves as the core member of the “Community to Promote High-Quality Development of Traditional Chinese Medicine”, vigorously promoting the high-quality basic research of TCM, high-quality medicinal material production, and new drug development, and striving to promote the implementation of the “14th Five-Year TCM Plan” to contribute to Healthy China. Dong’e Ejiao brand construction achievements have been included as a classic case in the “World Brand Yearbook (2024)” published by Xinhua News Agency. In 2025, Dong’e Ejiao was ranked among the “China’s Top 500 Most Valuable Brands” for the 16th time, with a brand value of RMB 49.7 billion, an increase of 11% compared with 2024. 2. Advantages of excellent products: By deepening the quality control technology and establishing a digital quality control system, adopting a preventive quality control approach and centering on company-wide quality improvement initiatives, the Company continuously enhances the efficiency of quality management and the precision of quality risk control. In 2024, it continued to maintain a 100% pass rate in random inspections, a 100% pass rate in certification audits, and zero quality accidents, while breaking new ground in quality management through advancements in quality control technology and mode. Notably, its “Building the Quality Control Mode of Life Cycle of Products” won the typical quality benchmark of Shandong Province. Five products, including Ejiao, Compound Ejiao Syrup, Peach Blossom Lady, Ejiao Jujube and Ejiao Powder, were selected into the first batch of “Liaocheng Excellent Products”. The company has fully implemented the Laboratory Information Management System (LIMS) across all its products and deployed a digital laboratory quality control system for the whole variety of food and drugs, enabling end-to-end on-line quality control covering material inspection, approval for release, environmental testing, and reagent test solution. This has increased the efficiency of inspection report issuance by 20% and reduced the manual entry error rate by 30%. It has also carried out in-depth company-wide quality improvement activities, including QC team initiatives, focusing on the improvement of the team’s ability to analyze and solve problems. There are abundant achievements in company-wide quality improvement activities, one of which has been selected into the QC competition of Central State-Owned Enterprises (CSOEs), two of which have won the titles of “Demonstration Level”, one of “Professional Level” and three of “Excellence Level” of China Association for Quality (CAQ), fully demonstrating the company’s outstanding capability in quality improvement. 3. Leading standards: Focusing on quality control and standard innovation for gel-based traditional Chinese medicines (TCMs) and research on innovative TCM preparations, its core technology achievement – “Construction and Application of Key Technology System for Quality Control and Standard Innovation of High Animal-type TCMs” – was awarded the Second Prize of the 2024 Shandong Science and Technology Progress Award, driving the gel-based pharmaceutical industry toward a more scientific and standardized quality system. It takes the lead in formulating standards for Ejiao Pearls and Syngnathidae in the Chinese Pharmacopoeia (2025), and participates in the formulation of 2 national standards and 1 industrial standard. Additionally, the international standard for gel-based TCMs has obtained project approved, leading the upgrading of animal-derived pharmaceutical industry toward greater standardization, regulation, and internationalization. Compound Ejiao Syrup has been incorporated into the Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Tumor-related Anemia, expanding its therapeutic scope and enhancing its market transformation potential, thereby helping to break new ground in the medical market for Compound Ejiao Syrup. 4. Scientific research platform advantage: Dong’e Ejiao has successfully obtained approval to establish the National Enterprise Technology Center and the Key Laboratory of Collagen for China Light Industry, and has established provincial-level program for Academician Shi Bi and Academician Chen Wei, in addition to successfully inaugurating the Shandong Key Laboratory for Research and Development of Gelatin Drugs, marking the centralized establishment of a range of high-level R&D platforms. Supported by these scientific research platforms, the company continuously implements its “One Center, Three Highlands, and N Alliances” R&D strategy. “One Center” means to consolidate efforts on the construction of the approved National Engineering and Technology Research Center for Gel-based TCMs, and build an original technology hub for gel-based pharmaceuticals, addressing the key common bottlenecks that constrain the development of the gel-based industry, while pioneering the innovative development of Chinese-style nourishment and healthy preservation. “Three Highlands” means to build a “Raw Material Conservation R&D Highland” and become the leader of value creation in the global donkey industry chain. Grounded in the scientific code of donkey breeding and raw material quality, it strengthens the quality assurance system at the source. Building a “Nourishing TCM R&D Highland” to advance the development of characteristic nourishing pastes and innovative TCMs, it integrates high-end academic and scientific research resources to conduct new drug screening and project approval around brain nourishing, tumor nourishing and other nourishing fields. It also creates a “Healthy Consumer Products R&D Highland” to become the most trusted leader in nourishment and health among the general public. Moreover, it has established a joint innovation laboratory with Jiangnan University, accelerating product innovation and research breakthroughs for health consumer goods. “N Union” means to co-establish several joint innovation platforms with top domestic scientific research institutes, supporting the achievement of strategic goals for scientific and technological innovation.

45 announcements tracked· Last: June 24, 2026

Key Financials

As of 2026-06-20T00:00:00.000+00:00
Revenue¥1.81bn
Net Profit¥454.8M
ROE4.21%
Debt Ratio20.02%
Monetary Funds¥6.15bn
Receivables¥506.6M
Goodwill¥16.0M
Total Shares644.0M

Announcements

45 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.